| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | 0.15 | 6e-06 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.14 | 1e-05 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.13 | 4e-05 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | 0.17 | 0.0005 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.24 | 0.001 |